MEG3 inhibits proliferation and promote apoptosis in osteoarthritis chondrocytes by miR-361-5p/wnt/β-catenin axis

doi:10.21203/rs.2.11513/v3

Download PDF

Research article

MEG3 inhibits proliferation and promote apoptosis in osteoarthritis chondrocytes by miR-361-5p/wnt/β-catenin axis

https://doi.org/10.21203/rs.2.11513/v3

This work is licensed under a CC BY 4.0 License

Journal Publication

published 30 Dec, 2019

Read the published version in BMC Medical Genomics →

You are reading this older preprint version

Read the latest preprint version →

Background: This study aimed to investigate the role of long noncoding RNA (lncRNA) maternally expressed 3 (MEG3) and related molecular mechanisms in osteoarthritis (OA). Methods: Patients with OA and patients undergoing thigh amputation were involved in OA group and control group, respectively. Cartilage tissues of all patients were isolated and cultured. Based on different transfection, MEG3 cells were grouped into Blank, pcDNA3.1-NC, pcDNA3.1-MEG3, si-NC, si-MEG3, pcDNA3.1-NC + mimics NC, pcDNA3.1-MEG3 + mimics NC, pcDNA3.1-NC + miR-361-5p mimics and pcDNA3.1-MEG3 + miR-361-5p mimics group. The cells transfected with pcDNA3.1-NC and pcDNA3.1-MEG3, and then cultured with XAV939 was named as pcDNA3.1-NC +XAV939 group and pcDNA3.1-MEG3 + XAV939 group respectively. The RT-qPCR was used to detect the expression of MEG3 and miR-361-5p . Moreover, Western blot, luciferase reporter assay, RIP, CCK-8 and flow cytometry analysis were performed to reveal the morphology, proliferation and apoptosis in cartilage cells. Finally, the histological analysis and immunostaining were performed on OA rat model. Results: The expression of lncRNA MEG3 and miR-361-5p in OA was significantly decreased and increased respectively than that in normal. Meanwhile, MEG3 was competitive binding with miR-361-5p in OA chondrocytes. Moreover, the Western blot and CCK-8 assay showed that MEG3 might inhibit cell proliferation and promote cell apoptosis via Wnt/β-catenin pathway. Finally, rat model analysis showed that MEG3 contributed to the cartilage matrix degradation. Conclusion: MEG3 and miR-361-5p might down-regulated and up-regulated respectively in the chondrocytes of OA patients. Furthermore, MEG3 might inhibit cell proliferation and promote cell apoptosis via miR-361-5p/Wnt/β-catenin axis in OA chondrocytes.

Orthopedics

Molecular Biology

osteoarthritis

chondrocytes

maternally expressed 3

miR-361-59

wnt/β-catenin signaling pathway

Osteoarthritis (OA) is a disease increasing with age and even induces serious pain and disability [1]. It lead to various pathological changes including articular cartilage degradation, synovial inflammation and subchondral osteoblast activation [2]. Since various genetic, biological, and biomechanical components are proved to be associated with OA [3], the molecular mechanisms underlying the progression of OA is not completely understood.

The lncRNAs play important regulatory roles in oncogenic pathways [4-8]. The biological function of lncRNAs is proved to be associated with knee OA progression [9]. As a member of lncRNA, maternally expressed 3 (MEG3) is proved to participated in the development of tumors [10]. Recently, MEG3 is found to be a potential target for OA, which was confirmed to participate in various cancer including lung cancer [11], breast cancer[12] and esophageal cancer [13]. Su et al. showed that MEG3 was suppressed and inversely related to vascular endothelial growth factor A levels in OA. [14]. Actually, the biological function of MEG3 is realized by targeting certain pathways such as wnt/β-catenin signaling pathway [15]. During this process, the wnt/β-catenin signaling related factors such as Matrix metallopeptidase 1 (MMP-1) and MMP-13 are highly overexpressed in OA [16]. Cui et al. showed that MEG3 was closed associated with wnt/β-catenin signaling pathway, and further play an important role in glioblastoma [17]. Xia et al. indicated that the suppression of MEG3 take part in the biological function of lung cancer cells via promoting the expression of wnt/β-catenin [16]. Meanwhile, pervious study shows that miR-361-5p hindered the tumor cells mobility via this pathway [18]. Interestingly, MEG3 is proved to be down-regulated and inversely associated with VEGF levels in OA [19]. Jin et al. indicated that the down-regulation of MEG3 leaded to OA progression via certain miRNA-target gene axis [20]. Although the effect of MEG3 in cancer progression via certain genes or pathways are mentioned in previous studies, the potential mechanism of MEG3 during OA progression is still unclear.

In the current analysis, the mechanism of lncRNA MEG3 and related pathways in OA was explored based on cartilage cells obtained from patients with OA (OA group) and artificial joint replacement (normal group). The RT-qPCR, Western blot, luciferase reporter assay, RNA immunoprecipitation (RIP), cholecystokinin (CCK-8) and flow cytometry analysis were performed to reveal the morphology, proliferation and apoptosis in cartilage cells. Finally, the histological analysis and immunostaining were performed on OA rat model. The study might provide a new target and theoretical basis for OA treatment.

Patients and grouping

The cartilage tissue of OA patients came from the knee joints of 30 patients who had undergone total knee arthroplasty. Meanwhile, the healthy cartilage tissue came from 20 patients who had not undergone OA or RA (rheumatoid arthritis). All patients voluntarily signed the informed notice. The current study obtained the approval of Ethics Committee of the hospital (ethic vote 198/203).

Cell culture

The femoral articular cartilage of the femur was obtained and cut. Then, it was digested by 0.2% type II collagenase, oscillation resolving for 40min at 37℃, washed by D-Hanks, and diluted in DMEM/F12 (Gibco, USA) combined with 10% FBS, 100 u/ml penicillin (Gibco, USA) as well as 100 mg/ml streptomycin (Gibco, USA). Then cells were culture in a saturated humidity incubator (37°C, 5% CO₂). The solution was changed every two days until the chondrocytes grew into sheets and covered more than 85% of the wall of the bottle [21]. The cells of 2 or 3 generations were enrolled for the further investigation.

Cell transfection

PcDNA3.1-MEG3 overexpression vector, si-MEG3 (Sangon Biotech, Shanghai, China), miR-361-5p mimics and miR-361-5p mimics NC (Guangzhou Reeber) were prepared, followed by cells transfection according to the instructions of the transfection reagent. Based on different transfection, osteoarthritic chondrocytes were divided into Blank group, pcDNA3.1-NC group, pcDNA3.1-MEG3 group, si-NC group, si-MEG3 group, pcDNA3.1-NC + mimics NC group, pcDNA3.1-MEG3 + mimics NC group, pcDNA3.1-NC + miR-361-5p mimics group and pcDNA3.1-MEG3 + miR-361-5p mimics group. All transfection was carried out by Lipfectamine 2000 transfection kit (Invirtrogn，USA) according to the instructions. Then, the samples were treated with pcDNA3.1-NC and pcDNA3.1-MEG3 were cultured for 48 h by adding 10 μmol/l of Wnt/β-catenin signaling pathway inhibitor XAV939 (Tocris Bioscience), which was named as pcDNA3.1-NC +XAV939 group and pcDNA3.1-MEG3+ XAV939 group respectively. After 48 hours, the samples were treated with IL-1β (10 ng / ml) for 24 hours. Finally, cells of each group were collected for following experiments.

Real-time fluorescent quantitative PCR

Total RNA (500 ng) from sample of each group was obtained as well as quantified using TRIzol reagent, and cDNA template was synthesized by reagent kit (invitrogen, San Diego, USA). GAPDH was used as reference (Table 1). The associated conditions were: 95°C for 3 min, 39 cycles at 95 °C for 10 s, 55 °C. Fluorescence signals were collected at the end points of each cycle extension, followed by the amplification curve investigation. Relative expression of candidate genes were calculated by 2^-∆∆CT method [22].

Luciferase reporter assay

The regulatory relation between MEG3 and miR-361-5p was revealed by using StarBase. A wild type (MEG3-WT) or mutant (MEG3-MUT) fragment of the MEG3 3'UTR containing miR-361-5p was synthesized. Then, the wild type or mutant were cloned into the pmirGLO reporter vector (Promega, USA). After inoculation of human chondrocytes in 24-well plates (5 × 105/well) for 24 hours, miR-361-5p mimic or miR-361-5p NC, MEG3-WT or MEG3-MUT were co-transfected into human chondrocytes by Lipofectamine 3000 (Thermo Fisher Scientific), followed by Kit (Promega, E1910, USA) detection 48 hours after transfection.

RIP assay

RIP was determined by using a Magna RIPTM RNA kit (Millipore, USA). Briefly, the cultured chondrocytes were further suspended in RIP lysis buffer (Solarbio). Then, cell extract was incubated overnight with RIP buffer containing human anti-Ago2 antibody beads (Millipore) (Input and normal IgG served as controls). Finally, RNA samples was extract using TRIzol reagent, followed by relative enrichment of MEG3 and miR-361-5p detection.

Western blotting

Cultured cells were treated with 100 μl/50mL protein lysate RIPA. Briefly, the extracted protein was quantified by bicinchoninic acid (BCA) method. A total of 50 g samples was investigated by 10% polyacrylamide gels, and transferred to polyvinylidenefluoride membranes (5% Skim milk/BSA). Samples was treated with primary antibodies including β-catenin (#8480), Non-phospho (Active) β-Catenin (#19807), MMP-1 (#54376), MMP-13 (#94808), cyclinD1(#2922), c-Myc (#9402), PCNA (#13110), Bax (#5023) and Bcl-2 (#4223) antibody (1:1000, Cell Signaling, Boston, USA), as well as Ki67 (ab92742), ADAMTS-5 (ab41037) and Aggrecan (ab36861) (Abcam, Cambridge, MA, USA) [20]. Then, samples were treated with the secondary antibody (1:5000, Biyuntian). Finally, the protein was stained with diaminobenzidine (DAB) kit. All experiments were repeated for 3 times.

CCK-8 assay

All cells were placed in 24-well plates (2 × 10³ cells/well, 37 °C and 5% CO₂). After being incubated for 0, 24, 48, 72 h, a total of 10 μL CCK-8 (Sigma-Aldrich) were mixed in samples for further incubation. OD₄₉₀ value was measured by enzyme-linked immunosorbent assay [23].

Flow cytometry assay

Simply, the cells were treated by trypsin combining with 200 μL Annexin V-FITC, incubated for 10 min in dark, and then washed with 200 μL PBS and 10 μL PI. Cell cycle was then detected by using flow cytometry (Beckman Coulter), followed by the data analysis.

OA rat model construction

Male SD rats (200-250 g) were obtained from the Experimental Animal Center of Taishan Medical College. All rats were anesthetized with intramuscular injection of sodium pentobarbital (0.05 mg/g, Chuangdong Co., Chongqing, China). Then, SD rats was traversed by the medial collateral ligament and destabilized by the medial meniscus (DMM). One week after the operation, si-NC, si-MEG3 (1×109 PFU, 20 μl) was injected into the knee joint of the recipient rat (n = 6 for each group, 20 μL per joint) twice a week for 4 weeks. Eight weeks after the operation, the rats were sacrificed with cervical dislocation method (external force dislocated the cervical vertebra of rat and disconnects the spinal cord from the cerebrospinal cord), and then the knee joints were harvested. All experiment was performed in Experimental Center of Taishan Medical College. This study was approved by the Laboratory Animal Ethics Committee of Taishan Medical College (No. 2019146), and all experiments were in accordance with the guide for the care and use of laboratory animal.

Histological and immunostaining investigation

Cartilage samples was placed in paraformaldehyde (4%), embedded in paraffin and cut into sample slice (5μm/slice). The cartilage destruction was evaluated by using the Safranin ‘O’ staining. Histological scores were performed according to the International Osteoarthritis Research Association (OARSI) grading system, which ranging from 0 (normal) to 6 (>80% represented the cartilage loss). Scores were determined from multiple serial sections of the knee joint of each mouse.

Statistical Analysis

The SPSS 18.0 (Chicago, IL, USA) was selected as the software for data analysis. Meanwhile, all the data in current investigation were represented as the mean ± standard deviation (SD). Significant differences between two groups were assessed using Student’s t-test, while least significant difference between means (LSD)-t multiple comparison test was processed for more than two groups. P < 0.05 was considered as statistically significant [24].

MEG3 regulated OA cell proliferation, apoptosis, and cartilage matrix degradation

Compared with Normal group, MEG3 in chondrocytes of OA group was significantly decreased (P < 0.001) (Figure 1A). After transfection with pcDNA3.1-MEG3 or MEG3 siRNA into OA chondrocytes, the expression of MEG3 in pcDNA3.1-MEG3 group was dramatically promoted compared with that in pcDNA3.1-NC group (P < 0.05). Moreover, compared with the si-NC group, the expression of MEG3 in the si-MEG3 group was significantly suppressed (Figure 1B) (P < 0.05). Moreover, the cell proliferation ability of the pcDNA3.1-MEG3 group was dramatically decreased than that of the pcDNA3.1-NC group (P < 0.05) (Figure 1C), while the cell proliferation ability of the si-MEG3 was dramatically promoted compared to the si-NC group (Figure 1D). Furthermore, compared with the pcDNA3.1-NC group, PCNA and the marker ki67 in the pcDNA3.1-MEG3 group was dramatically suppressed, and the expression of the PCNA and the marker ki67 in the pcDNA3.1-MEG3 group was dramatically promoted (Figure 1E). In addition, the apoptosis rate of pcDNA3.1-MEG3 group was significantly promoted compared with pcDNA3.1-NC group, and the apoptosis rate of si-MEG3 group was dramatically suppressed than that of si-NC group (Figure 1F). Compared with pcDNA3.1-NC group, Bcl-2 was up-regulated and Bax was suppressed in pcDNA3.1-MEG3 group, respectively. Meanwhile, compared with si-NC group, Bcl-2 was suppressed, while Bax was promoted in si-MEG3 group, respectively (Figure 1G).

The rat OA model analysis showed that compared with pcDNA3.1-NC group, MMP1, MMP13, ADAMTS-5 was up-regulated, while Collagen II and Aggrecan expression were down-regulated in cDNA3.1-MEG3 group (Figure 1H). Compared with si-NC group, MMP1, MMP13, ADAMTS-5 was down-regulated, while Collagen II and Aggrecan was promoted in si-MEG3 group.

MEG3 competitive binding miR-361-5p in OA chondrocytes

The binding sites of MEG3 and miR-361-5p were predicted using StarBase (Figure 2A). The luciferase reporter assay demonstrated that MEG3 regulated miR-361-5p, MEG3-Wt and miR-361-5p mimics co-transfected cells with significantly reduced luciferase activity (Figure 2B). Meanwhile, the RIP assay showed that compared with lgG control group, MEG3 and miR-361-5p were dramatically overexpressed in the Ago2 pellet (Figure 2C). After transfection of pcDNA3.1-MEG3 or MEG3 siRNA into OA chondrocytes, miR-361-5p was down-regulated when compared with pcDNA3.1-NC group, while miR-361-5p was significantly up-regulated when compared with si-NC group (Figure 2D). Moreover, the expression of MEG3 in OA group and normal group detected by RT-qPCR showed that miR-361-5p was dramatically promoted in chondrocytes of OA group when compared with normal group (P < 0.001) (Figure 2E). Furthermore, the Spearman correlation analysis showed a negative correlation between expression of MEG3 and miR-361-5p (r = -0.529, p = 0.0026) (Figure 2F).

The effect of MEG3 on proliferation, apoptosis and cartilage matrix degradation of OA chondrocytes was inhibited by miR-361-5p

Compared with pcDNA3.1-NC + mimics NC group, miR-361-5p was decreased in pcDNA3.1-MEG3 + mimics NC group, while miR-361-5p was promoted in pcDNA3.1-NC + miR-361-5p mimics group (Figure 3A). Moreover, the cell proliferation ability of pcDNA3.1-NC + miR-361-5p mimics group was stronger than that of pcDNA3.1-NC + mimics NC group, while the proliferation ability of pcDNA3.1-MEG3 + miR-361-5p mimics group was higher than that of pcDNA3.1-NC + mimics NC group (Figure 3B). The expression of PCNA and ki67 in NA3.1-NC + miR-361-5p mimics group was decreased than that in pcDNA3.1-NC + mimics NC group (Figure 3C). Furthermore, the apoptosis rate of pcDNA3.1-NC + miR-361-5p mimics group was down-regulated compared with pcDNA3.1-NC + mimics NC group (P<0.05) (Figure 3D). Compared with pcDNA3.1-NC + mimics NC group, Bcl-2 and Bax was significant down-regulated and up-regulated respectively in pcDNA3.1-NC+miR-361-5p mimics group (P<0.05) (Figure 3E). In addition, compared with pcDNA3.1-NC + mimics NC group, MMP1, MMP13, ADAMTS-5 and Collagen II/Aggrecan were significant down-regulated and up-regulated respectively in pcDNA3.1-NC+miR-361-5p mimics group (all P<0.05) (Figure 3F).

MEG3 regulated the expression of Wnt/β-catenin signaling pathway

Western blot was used to detect the expression of Wnt/β-catenin pathway protein in chondrocytes of each group. Compared with the si-NC group, Wnt/β-catenin pathway proteins (Active-β-catenin, β-catenin, Wnt3a, Wnt5a, cyclin D1, c-Myc) were significantly up-regulated in pcDNA3.1-NC and pcDNA3.1-MEG3 groups (all P < 0.05). Compared with the pcDNA3.1-MEG3 group, Wnt/β-catenin pathway proteins were dramatically down-regulated in the si-MEG3 group (Figure 4A). Moreover, the transfection of miR-361-5p mimics reduced the expression of Wnt/β-catenin pathway related proteins, and co-transfection of pcDNA3.1-MEG3 with miR-361-5p mimics counteracted the effect of MEG3 overexpression (Figure 4B). Furthermore, the expression level of Wnt/β-catenin pathway proteins were dramatically suppressed in pcDNA3.1-MEG3 + XAV939 group than other groups (all P < 0.05) (Figure 4C).

Wnt pathway inhibitor reversed the role of MEG3 in OA chondrocytes

After treatment with XAV939, the proliferation (Figure 5A) and apoptosis (Figure 5B) in pcDNA3.1-MEG3 + XAV939 group was significant increased and decreased respectively (all P < 0.05) than those in pcDNA3.1-MEG3 group. Meanwhile, compared with pcDNA3.1-MEG3 group, the expression of Bcl-2 and Bax was up-regulated and down-regulated respectively in pcDNA3.1-MEG3 + XAV939 group (Figure 5C). Moreover, compared with pcDNA3.1-MEG3 group, the expression of MMP1, MMp13 and ADAMTS-5 were down-regulated, while Collagen II and Aggrecan were up-regulated in pcDNA3.1-MEG3 + XAV939 group (Figure 5D).

MEG3 contributed to the cartilage matrix degradation in rats

Compared with the OA group, the expression of MEG3 in and control group and OA + si-MEG3 group was both decreased (Figure 6A). Injection of si-MEG3 effectively reduced the cartilage damage of the operation, protected the cartilage from degradation, and reduced the loss of proteoglycan and joint soft cell (Figure 6B). Moreover, the interference with MEG3 inhibited cartilage bone marrow matrix degradation (Figure 6C).

Although OA affecting about 237 million people worldwide [25], the detail molecule mechanism of OA is still not fully investigated until now. In the current study, the RT-qPCR analysis revealed that the lncRNA MEG3 and miR-361-5p in OA was significantly decreased and increased respectively than that in normal. Meanwhile, StarBase prediction showed that the MEG3 was competitive binding miR-361-5p in OA chondrocytes. Moreover, the Western blot and CCK-8 assay showed that MEG3 might inhibit cell proliferation and promote cell apoptosis via Wnt/β-catenin pathway.

As a maternally expressed imprinted gene, MEG3 can be found in various normal tissues except for tumor cells [11, 26]. A previous study shows that the downregulation of MEG3 is associated with the expression of tumor genes in epithelial cells [27]. Ying et al. showed that the suppression of MEG3 was related with the progression of bladder cancer [28]. A previous study shows that the low expression induced by gene knockdown can inhibit apoptosis of chondrocyte in OA rat model [30]. Actually, the low expression of MEG3 has also been reveled in OA. MEG3 has been proved to participate in the development of OA via miR-16/AMAD7 interaction [20]. A previous study indicates that MEG3 is down-regulated and inversely associated with vascular endothelial growth factor A levels in OA. [14]. In the current study, the RT-qPCR analysis showed that the expression of MEG3 in OA group was significantly decreased than that in normal group. Thus, we speculated that MEG3 might down-regulated in the chondrocytes of patients with OA.

MEG3 has been proved to play an vital role in the process of tumor in previous studies [31]. Xu et al. revealed that knockdown of MEG3 induced proliferation of rat chondrocytes and inhibited apoptosis [20]. Sun et al. revealed that down-regulated MEG3 promoted cell proliferation in gastric cancer [29]. A previous study shows that MEG3 take part in the process of lung cancer cells function, and suppress apoptosis [32]. Actually, the biological function of MEG3 is realized by involving certain signaling pathway. The previous mechanics, inflammatory mediators and aging collide studies indicate that wnt/β-catenin signaling is critically involved in these processes [34]. In fact, the down-regulated MEG3 can activate in wnt/β-catenin signaling pathway, and then enhance cisplatin resistance in lung and glioma cancer [16]. Liu et al. indicated that MEG3 participated in the progression of carcinoma by via the this pathway [35]. Gao et al. showed that the MEG3 low-expression contributed to retinoblastoma progression via wnt/β-catenin pathway [36]. In adult β‐catenin conditional activation rat, OA-like phenotype were shown in articular chondrocytes [37]. In this study, the Western blot, CCK-8 and flow cytometry assay showed that MEG3 not only promoted the proliferation, but also inhibited apoptosis in OA chondrocytes cells. Meanwhile, StarBase prediction showed that MEG3 competitive binding miR-361-5p in OA chondrocytes. Moreover, the RT-qPCR analysis for expression of PCNA and ki67 showed that the effect of MEG3 on proliferation, apoptosis and cartilage matrix degradation of OA chondrocytes was inhibited by miR-361-5p. Importantly, to reveal whether a target gene participates in certain pathway, the detection of core protein (β-catenin) and related factors (e.g. MMP-1, MMP-133) in wnt/β-catenin signaling pathway is needed [38]. A previous study indicates that the low expression of MMP13 is an effective method for decrease articular cartilage loss in OA models [39]. In the current study, MMP-1, MMP-13 and β-catenin detection proved that EMG3 involved in the regulation of Wnt/β-catenin during OA progression. Thus, based on these results in current study, we speculated that MEG3 might inhibit cell proliferation and promote cell apoptosis via miR-361-5p/Wnt/β-catenin axis in OA chondrocytes.

In conclusion, MEG3 and miR-361-5p might down-regulated and up-regulated respectively in the chondrocytes of OA patients. Furthermore, MEG3 might inhibit cell proliferation and promote cell apoptosis via miR-361-5p/Wnt/β-catenin axis in OA chondrocytes.

osteoarthritis OA

long noncoding RNA lncRNA

Long noncoding RNAs lncRNAs

maternally expressed 3 MEG3

Ethics approval and consent to participate: The ethics committee of The Third Hospital of Hebei Medical University approved the study. This study was written informed consent from the patients.

Consent for publication: Not applicable.

Availability of data and material: All data generated or analyzed during this study are included in this published article and its supplementary information files.

Competing interests: The authors declare that they have no competing interests.

Funding: Not applicable.

Authors' contributions: AYW, NXH and YFZ designed and analyzed the experiment, and was a major contributor in writing the manuscript. YZC, CHS, YL and YS performed the experiment. All authors read and approved the final manuscript.

Acknowledgements: Not applicable.

Felson, D.T., et al., The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis & Rheumatology, 1987. 30(8): p. 914-918.
Battistelli, M., et al., Cell death in human articular chondrocyte: a morpho-functional study in micromass model. Apoptosis, 2014. 19(10): p. 1471-1483.
Johnson, V.L. and D.J. Hunter, The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol, 2014. 28(1): p. 5-15.
Jain, S., et al., Long non-coding RNA: Functional agent for disease traits. Rna Biology, 2017. 14(5): p. 1-14.
UA, Ø., et al., Long noncoding RNAs with enhancer-like function in human cells. Médecine Sciences M/s, 2010. 143(1): p. 46-58.
Maass, P.G., et al., A misplaced IncRNA causes brachydactyly in humans. Journal of Clinical Investigation, 2012. 122(11): p. 3990-4002.
Kotake, Y., et al., Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene, 2011. 30(16): p. 1956.
Khaitan, D., et al., The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Research, 2011. 71(11): p. 3852.
Wang, K., et al., Putative functional variants of lncRNA identified by RegulomeDB were associated with knee osteoarthritis susceptibility. Bmc Musculoskeletal Disorders, 2018. 19(1): p. 284-.
Yanhua, L., et al., Long noncoding ribonucleic acids maternally expressed gene 3 inhibits lung cancer tumor progression through downregulation of MYC. Indian Journal of Cancer, 2015. 52(7): p. 190.
Kruer, T.L., et al., Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway. Plos One, 2016. 11(11): p. e0166363.
Zhang, W., et al., LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer. Biomedicine & Pharmacotherapy, 2017. 91: p. 312-319.
Dong, Z., et al., Aberrant Methylation-mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Molecular Cancer Research, 2017. 15(7): p. 800-810.
Li, X., et al., Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3. Experimental & Therapeutic Medicine, 2018. 15(4): p. 3856-3864.
Li, X., L. Xue, and Q. Peng, Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/β-catenin signaling pathway. Oncology Letters, 2018. 15(6): p. 8470-8476.
Xia, Y., et al., Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway. Molecular Medicine Reports, 2015. 12(3): p. 4530.
Cui, X., et al., MEG-3-mediated Wnt/β-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma. Oncology Letters, 2018. 16(3): p. 2797-2804.
Tian, L., et al., MiR-361-5p inhibits the mobility of gastric cancer cells through suppressing epithelial-mesenchymal transition via the Wnt/β-catenin pathway. Gene, 2018: p. S037811191830756X-.
Su, W., et al., The Long Noncoding RNA MEG3 Is Downregulated and Inversely Associated with VEGF Levels in Osteoarthritis. Biomed Research International, 2015. 2015: p. 1-5.
Xu, J. and Y. Xu, The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis. Cell & Bioscience, 2017. 7(1): p. 69.
Wei, L., et al., CD95-induced osteoarthritic chondrocyte apoptosis and necrosis: dependency on p38 mitogen-activated protein kinase. Arthritis Res Ther., 2006. 8(2): p. R37.
Livak KJ, S.T., Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T))Method. METHODS, 2001. Dec;25(4): p. 402-408.
Zhang, S., X. Yang, and M. Fan, BioAggregate and iRoot BP Plus optimize the proliferation and mineralization ability of human dental pulp cells. International Endodontic Journal, 2013. 46(10): p. 923-9.
Xu, S., et al., MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1. Oncotarget, 2015. 6(28): p. 26457-26471.
Disease, G., I. Incidence, and P. Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017. 390(10100): p. 1211-1259.
Wei, G.H. and X. Wang, lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci, 2017. 21(17): p. 3850-3856.
Zhou, C., et al., LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation. Oncogene, 2017. 36(27): p. 3878-3889.
Ying, L., et al., Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Molecular Biosystems, 2013. 9(3): p. 407-411.
Sun, M., et al., Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumor Biology, 2014. 35(2): p. 1065-1073.
Abouheif, M.M., Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology, 2010. 49(11): p. 2054-60.
Hu, D., et al., Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3. Biochemical & Biophysical Research Communications, 2016. 471(2): p. 290-295.
Lu, K., et al., Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer,13,1(2013-10-07), 2013. 13(1): p. 461-461.
Clevers, H. and R. Nusse, Wnt/β-Catenin Signaling and Disease. Cell, 2012. 149(6): p. 1192-1205.
Wang, Z.Y. and W.Y. Wang, Pathogenesis of osteoarthritis and its relationship with the Wnt/β-catenin pathway. Orthopedic Journal of China, 2009.
Liu, Z., et al., Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT/Î²-catenin signaling pathway. Oncology Letters, 2017. 14(4): p. 4053-4058.
Gao, Y. and X. Lu, Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway. Tumor Biology, 2016. 37(2): p. 1461-1469.
Zhu, M., et al., Activation of β‐Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis‐Like Phenotype in Adult β‐Catenin Conditional Activation Mice. Journal of Bone and Mineral Research, 2010. 24(1): p. 12-21.
MacDonald, B.T., K. Tamai, and H. Xi, Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases. Developmental Cell, 2009. 17(1): p. 9-26.
Wang, M., et al., MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Research & Therapy, 2013. 15(1): p. 1-11.

Table 1 The amplification primer used for current RT-qPCR analysis

Name of primer	Sequences
LncRNA MEG3	5′-CTGCCCATCTACACCTCACG-3′
	5′-CTCTCCGCCGTCTGCGCTAGGGGCT-3′
GADPH	5′-TGCACCACCAACTGCTTAGC-3′
	5′-GGCATGCACTGTGGTCATGAG-3′
miR-361-5p	5′-ATAAAGTGCTGACAGTGCAGATAGTG-3′
	5′-TCAAGTACCCACAGTGCGGT-3′
U6	5′-CTCGCTTCGGCAGCACA-3′
	5′-AACGCTTCACGAATTTGCGT-3′

Notes: MEG3, maternally expressed 3; GADPH, glyceraldehyde-3-phosphate dehydrogenase; RT-qPCR, real-time fluorescence quantitative polymerase chain reaction.

ARRIVEchecklist.docx

Download PDF

Journal Publication

published 30 Dec, 2019

Read the published version in BMC Medical Genomics →

Editorial decision: Major revision
11 Oct, 2019
Review #2 received at journal
10 Oct, 2019
Review #1 received at journal
21 Sep, 2019
Reviewer #2 agreed at journal
19 Sep, 2019
Reviewers invited by journal
16 Sep, 2019
Reviewer #1 agreed at journal
16 Sep, 2019
Editor assigned by journal
06 Sep, 2019
Submission checks completed at journal
05 Sep, 2019
Editor invited by journal
05 Sep, 2019

You are reading this older preprint version

Read the latest preprint version →

MEG3 inhibits proliferation and promote apoptosis in osteoarthritis chondrocytes by miR-361-5p/wnt/β-catenin axis

Status:

Journal Publication

Version 3

Abstract

Figures

Background

Methods

RIP assay

Results

Discussion

Conclusions

Abbreviations

Declarations

References

Table

Supplementary Files

Status:

Journal Publication

Version 3